Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
*New clinical data from Phase 1 trial of ZW191 to be presented in an oral presentation on April 21*Preclinical data highlight combination potential fo
